ClinicalTrials.gg
Drug

Selexipag clinical trials

Also written ACT-293987, JNJ-67896049 and Uptravi.

studies test it
25
open now
1
in phase 3
9
first study started
2009

How each study uses selexipag is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the selexipag studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Dec 2015 · UPTRAVI · NDA 207947 (FDA, Drugs@FDA)
European Union
12 May 2016 · Uptravi · EMEA/H/C/003774 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Selexipag
18

Brand

Uptravi
3

Development codes

ACT-293987
13
JNJ-67896049
5

Studies by the year they started

25 studies that test it; most in 2016 (4)

Studies that test selexipag, by start year
YearStudies
20091
20101
20122
20141
20152
20164
20172
20182
20191
20202
20213
20221
20231
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
4
Phase 3
9
Phase 4
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 23 · Other 2

Actelion (21) · Humanis Saglık Anonim Sirketi (2) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · University of Sao Paulo General Hospital (1)

Often tested with

Tested in the same studies.

Riociguat (1) · Sotatercept (1) · Clopidogrel (1) · Gemfibrozil (1) · Rifampin (1) · Midazolam (1) · Moxifloxacin (1) · Macitentan (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test selexipag, phase 3 first.

Studies

Open first, then newest update. How each study uses selexipag is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 25

See all 25 studies that test selexipag →

Given beside what is tested · 1 — selexipag is usual care or a partner of the new treatment

Codes

What other systems call selexipag · ClinicalTrials.gg INT005165

  • MeSH (NLM) C523468selexipagConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 5EXC0E384LSELEXIPAGConfirmed FDA, NLM, Wikidata
  • RxNorm 1729002Confirmed FDA, Wikidata
  • Wikidata Q15424759selexipagConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152321SelexipagOne source FDA
  • DrugBank DB11362One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.